Medicare Enrolled
Dr. Ankur Khosla, MD
Pain Medicine · Shenandoah, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khosla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khosla? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khosla
Dr. Ankur Khosla is a pain medicine in Shenandoah, TX, with 14 years in practice. Based on federal Medicare data, Dr. Khosla performed 42,436 Medicare services across 2,229 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khosla received a total of $210,873 from 50 pharmaceutical and/or device companies across 1000 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khosla is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice▲ Top 1% volume in TX$ $210,873 industry payments
Medicare Practice Summary
Medicare Utilization ↗42,436
Medicare services
Top 1% in TX for pain medicine
2,229
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,031 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Capsaicin pain patch (Qutenza) | 37,801 | $2 | $10 |
| Office visit, established patient (30-39 min) | 1,543 | $93 | $330 |
| Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | 601 | $31 | $148 |
| Office visit, established patient (20-29 min) | 367 | $68 | $222 |
| Insertion of spinal neurostimulator electrode array through skin | 351 | $252 | $5,979 |
| New patient office visit (45-59 min) | 302 | $117 | $505 |
| Steroid injection (triamcinolone) | 198 | $1 | $8 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 137 | $40 | $170 |
| Assessment of emotional or behavioral problems | 101 | $3 | $16 |
| Destruction of peripheral nerve or branch | 86 | $161 | $539 |
| Insertion of spinal neurostimulator generator or receiver | 84 | $160 | $1,155 |
| Injection of substance into middle or upper spine canal using imaging guidance | 83 | $82 | $768 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 67 | $141 | $577 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 49 | $149 | $1,278 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 49 | $46 | $526 |
| Injection of cell or tissue-based material into spinal disc of lower back accessed through skin, first level | 48 | $80 | $3,096 |
| Fusion of pelvic joint using imaging guidance | 37 | $670 | $1,747 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 37 | $109 | $799 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 36 | $62 | $403 |
| Fusion of spine in lower back | 34 | $1,265 | $5,018 |
| Remote patient monitoring management, 20 min/month | 33 | $37 | $157 |
| Remote patient monitoring device, 30 days | 32 | $37 | $195 |
| Placement of stabilizing device to back of 1 spine bone in neck | 31 | $632 | $2,423 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 31 | $54 | $575 |
| Graft of donor bone to spine | 30 | $92 | $358 |
| Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | 27 | $757 | $3,096 |
| Joint injection, major joint | 27 | $45 | $188 |
| Injection of anesthetic agent and/or steroid into spine and pelvis nerve using imaging guidance | 26 | $216 | $814 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 26 | $145 | $1,289 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 25 | $122 | $835 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 25 | $69 | $415 |
| Injection of substance into lower spine canal using imaging guidance | 15 | $190 | $754 |
| Heat destruction of intraosseous basivertebral nerve in bones of spine in lower back, first two bones | 15 | $379 | $1,431 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 15 | $14 | $59 |
| Fusion of sacroiliac joint between spine and pelvis with bone graft, accessed through skin using imaging guidance | 14 | $670 | $1,747 |
| Set-up and patient education for remote monitoring of therapy | 14 | $14 | $60 |
| Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, first 20 minutes per calendar month | 14 | $37 | $152 |
| Partial removal of spine bone with release of lower spinal cord or nerves and/or removal of disc | 13 | $384 | $3,064 |
| Device supply with scheduled recording and transmission for remote monitoring of musculoskeletal system, per 30 days | 12 | $37 | $168 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
1.8% medium
98.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$210,873
Total received (2018-2024)
Avg $30,125/year across 7 years
Top 2% in TX for pain medicine
50
Companies
1,000
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$74,668 (35.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$67,989 (32.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$56,432 (26.8%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$11,784 (5.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$37,728
2023$50,595
2022$65,301
2021$32,338
2020$15,375
2019$5,938
2018$3,599
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$55,667
Spinal Simplicity, LLC
$54,166
SurGenTec
$35,888
Averitas Pharma Inc.
$23,268
BOSTON SCIENTIFIC CORPORATION
$11,849
Boston Scientific Corporation
$7,794
PAINTEQ LLC
$4,317
GRT US Holding, Inc.
$2,584
Medtronic USA, Inc.
$2,397
Nevro Corp.
$1,967
SI-BONE, Inc.
$1,849
Relievant Medsystems, Inc.
$1,437
Vertiflex, Inc.
$1,301
Vertos Medical, Inc.
$1,228
ABBVIE INC.
$702
Pacira Pharmaceuticals Incorporated
$663
SPINEFRONTIER, INC.
$495
Saluda Medical Americas, Inc.
$428
SI-BONE, INC.
$405
Nalu Medical, Inc.
$223
Azurity Pharmaceuticals, Inc.
$213
Foundation Fusion Solutions, LLC
$212
TISSUETECH, INC.
$211
AbbVie Inc.
$181
Stimwave Technologies Incorporated
$146
Arbor Pharmaceuticals, Inc.
$142
ARBOR PHARMACEUTICALS, INC.
$127
SPR Therapeutics, Inc
$96
Flexion Therapeutics, Inc.
$91
Almatica Pharma LLC
$90
Flowonix Medical Incorporated
$79
BioTissue Holdings, Inc.
$71
Amgen Inc.
$56
Lundbeck LLC
$55
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$50
PFIZER INC.
$48
BIOTRONIK NRO, Inc.
$46
BIOTISSUE HOLDINGS, INC.
$44
Allergan, Inc.
$42
Avanos Medical
$37
Teva Pharmaceuticals USA, Inc.
$34
Horizon Therapeutics plc
$29
Medtronic, Inc.
$27
Kyowa Kirin, Inc.
$23
Zyla Life Sciences, Inc.
$20
Ultragenyx Pharmaceutical Inc.
$20
Scilex Pharmaceuticals Inc.
$16
Allergan Inc.
$15
BioDelivery Sciences International, Inc.
$14
Lilly USA, LLC
$11
Top 3 companies account for 69.1% of total payments
Associated products mentioned in payments ›
3D GraftRasp System · AJOVY · ASCENDA · AUTOFILL · Aimovig · Axium INS DRG IPG · Axium Sheath Braided DRG · BELBUCA · BOTOX · BOTOX - NEUROLOGY · CFNS StimQ Peripheral Nerve StimulatorSystem · Crysvita · EMGALITY · ENTRADA · ETERNA · Evoke · Evoke SCS · Exparel · FIXATE · GENERAL THERAPIES · GENERAL PAIN MANAGEMENT · GRALISE · HA MINUTEMAN G3-R · HORIZANT · Horizant · IFUSE IMPLANT · INTELLIS · ION Facet Screw · ION Facet Screw System · IONICRF · Inspan · Intracept · Iovera · KYPHON Balloon Kyphoplasty · MYSTIM · Minuteman · NAPRELAN · NEOX · NT1100 NT2000iX Simplicity · NURTEC ODT · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · OCTRODE · ON-Q* PUMP AND ACCESSORIES · Octrode SCS Leads · Omnia · PAINTEQ · PENNSAID · PENTA · PROCLAIM · PRODIGY · PROKERA · Penta SCS Leads · Proclaim DRG IPG · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · Prometra II · Prospera · QULIPTA · QUTENZA · Quattrode Leads SCS Leads · Qutenza · SCS IPGs · SCS leads · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · SUPERION · SWIFT-LOCK · SYNCHROMED · Senza Spinal Cord Stimulation System · SlimTip lead DRG Lead · StimQ Receiver Stimulator Kit Channel A US w/Receiver · Superion · Superion ISS · Swift-Lock SCS · TiLink · Tripole SCS Leads · UBRELVY · VECTRIS · VRAYLAR · VYEPTI · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (35%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pain medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for pain medicine in TX.
Equivalent to $497 per 100 Medicare services performed
Geographic Context
Pain Medicines within 10 mi
27
Per 100K population
4.1
County median income
$97,266
Nearest hospital
HOUSTON METHODIST THE WOODLANDS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Khosla is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (mixed engagement, top 2%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Khosla experienced with capsaicin pain patch (qutenza)?
Based on Medicare claims data, Dr. Khosla performed 37,801 capsaicin pain patch (qutenza) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khosla receive payments from pharmaceutical companies?
Yes. Dr. Khosla received a total of $210,873 from 50 companies across 1,000 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khosla's costs compare to other pain medicines in Shenandoah?
Dr. Khosla's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khosla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Shenandoah
Browse pain medicines in Shenandoah ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in TX
Pain Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in TX
Which TX pain medicines receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Spinal Simplicity, LLC Payments to Doctors
See all physicians who received payments from Spinal Simplicity, LLC.
By company
SurGenTec Payments to Doctors
See all physicians who received payments from SurGenTec.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology